FluxMPS™ RPMI 1640 Medium, High Glucose & 25mM HEPES w/o L-Glutamine, Sodium Pyruvate: 1X Liquid

Product#: DCP-RPMIGH-QP1X
$49.50
DCP-RPMIGH-QP1X
Availability:
Ships in 48 hours

warning For Research Use Only (RUO). Not intended for clinical, diagnostic, or therapeutic use in humans.
verified ISO 13485 Certified Manufacturing

FluxMPS™ RPMI 1640 Medium, High Glucose & 25mM HEPES w/o L-Glutamine, Sodium Pyruvate: 1X Liquid

Contains Sodium Bicarbonate Contains Phenol Red Contains HEPES (25mM) Contains Calcium Contains Magnesium Contains High Glucose Without L-Glutamine Without Sodium Pyruvate

FluxMPS™ DCP-RPMIGH-QP1X is a Microfluidics Suitable, ultra-filtered high-glucose RPMI 1640 formulation with 25 mM HEPES supplementation, engineered for organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.

  • High glucose (4.5 g/L) RPMI 1640 base with 25 mM HEPES supplementation for enhanced open-bench pH buffering
  • Formulated without L-Glutamine and without Sodium Pyruvate — add at time of use per your protocol
  • Quadruple-stage filtration (0.1 µm ×2 + 0.04 µm ×2) reaching a validated 0.04 µm final polish
  • Endotoxin release specification: < 0.05 EU/mL (LAL, USP <85>)
  • Sodium bicarbonate (2000 mg/L) buffered; 5% CO₂ recommended
  • Manufactured under an ISO 13485:2016 quality management system with full lot traceability
  • 39 verified ingredients per lot with full CAS raw-material traceability
CAT. NO.
DCP-RPMIGH-QP1X | Cell culture media UNSPSC: 41116155 | Commodity: Molecular biology and cell culture growth media | (UNv260801)
RPMI 1640 Medium, High Glucose & 25mM HEPES w/o L-Glutamine, Sodium Pyruvate: 1X Liquid
  • Glucose4500.000 mg/L
  • L-GlutamineNone / Not added
  • Sodium PyruvateNone / Not added
  • pH (USP <791>)7.4
  • Osmolality (USP <785>)Contact for specification
  • Endotoxin (USP <85>)< 0.05 EU/mL
  • Filtration0.1 µm ×2 + 0.04 µm ×2
  • Storage2–8°C, away from light
  • Shelf Life12 months from date of manufacture, unopened
  • ShippingCold pack
ISO 13485:2016 USP <85> <785> <788> RUO
Why FluxMPS™

Engineered where standard media fails

Conventional 0.22 µm–filtered media passes mycoplasma-sized organisms, subvisible particulates, and endotoxin fragments that confound sensitive cell assays.

filter_alt

Microchannel-safe purity

0.04 µm final filtration; USP <788> particulate compliance. Low-particulate media for OoC microfluidic chips.

target

Total metabolic control

Defined high-glucose, HEPES-supplemented base allows precise control of carbon source and buffering inputs; add L-glutamine and pyruvate to your own specification.

water_drop

Ultrapure-grade water

Type 1 water, 18.2 MΩ·cm resistivity, with tight trace-metal and total organic carbon (TOC) control to minimize extraneous chemical background.

visibility

Low background for imaging

Ultra-low particulate baseline supports confocal, biosensor, and live-cell imaging applications on-chip.

science

Rich, stable nutrient profile

39 verified ingredients per lot. Full CAS traceability. Micro-batch precision manufacturing.

tune

Customization on demand

pH, nutrient concentrations, HEPES, and component modifications available. Contact support@diagnocine.com.

Purity Architecture

Quadruple-stage filtration system

Four serial filtration stages — two dedicated 0.1 µm prefilter + 0.04 µm final-filter pairs — reaching a validated 0.04 µm final pore size, with aseptic fill under ISO Class 5 (Class 100) conditions.

  1. 1

    0.1 µm Prefiltration I

    Large particulate, cell debris & protein aggregate removal; protects the first 0.04 µm final filter cartridge.

  2. 2

    0.04 µm Final filtration I

    First 0.04 µm pass; retains sub-micron particulates and microaggregates that pass a conventional 0.22 µm filter.

  3. 3

    0.1 µm Prefiltration II

    Second dedicated prefilter, protecting the second 0.04 µm cartridge.

  4. 4

    0.04 µm Final filtration II — Polish

    Ultimate polishing filter; aseptic fill & finish under ISO Class 5 (Class 100) conditions.

Performance vs. conventional media

5×
Cleaner than 0.22 µm media by particulate count
0.04
µm Final pore size — sub-mycoplasma polishing
Sterility & Mycoplasma: No growth after 14-day incubation (USP <71>). Mycoplasma risk is controlled by 0.1 µm mycoplasma-retentive filtration at every production stage (not tested per lot).
Grade: This product is Microfluidics Suitable, filtered to a 0.04 µm final cut-off. It is not an MPS Grade product — that designation is reserved for the 0.01 µm ultra nano-filtered line, which adds 0.02 µm and 0.01 µm stages after the 0.04 µm polish. For applications requiring the 0.01 µm cut-off, contact support@diagnocine.com.
FluxMPS™ DCP-RPMIGH-QP1X Quadruple-stage filtration system (0.1 μm x2 + 0.04 μm x2) ? RPMI 1640 High Glucose HEPES cell culture media for organ-on-a-chip and microfluidic applications | Diagnocine
Figure 1. FluxMPS™ Quadruple-stage filtration system (0.1 µm ×2 + 0.04 µm ×2) — DCP-RPMIGH-QP1X.
© Diagnocine® — DCP-RPMIGH-QP1X
Applications

OoC and MPS Applications

FluxMPS™ DCP-RPMIGH-QP1X delivers Microfluidics Suitable purity for organ-on-a-chip and microfluidic applications.

Automated Bioreactors & Robotics

Next-Generation System Uptime

Optional 0.01 µm (10 nm) ultra-filtered MPS Grade variant available on request for automated bioreactors and robotic perfusion systems.

  • Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates that foul automated systems
  • Valve & Sensor Protection: Reduces micro-fouling in automated perfusion and recirculation systems
  • Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture runs

Inquiry Required: Contact support@diagnocine.com to request the 0.01 µm MPS Grade variant.

Microfluidics

Micro Physiological System (MPS) & Chip

0.04 µm filtered media for organ-on-a-chip, tissue-on-a-chip, and body-on-a-chip where low-particulate media reduces channel fouling.

OoCToCBoCLoCMPS
Cancer Biology

Cancer Cell Lines & Metabolic Research

Supports NCI-60 cancer lines and Warburg effect metabolic studies with a high-glucose, defined nutrient base.

MCF-7MDA-MB-231HeLaJurkat
Stem Cell Biology

iPSC-Derived Models

Ultra-clean base for iPSC differentiation protocols requiring defined, low-particulate media.

iPSC-NeuronsiPSC-CMiPSC-Hep
Vascular Biology

Endothelial & Primary Cells

Low-particulate formulation for primary cells and endothelial monolayer studies on-chip.

HUVECsHAECsPrimary hepatocytes
Metabolomics

Metabolic Flux Analysis

Defined high-glucose formulation supports ¹³C isotope tracing and NMR metabolomics. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium.

¹³C tracingNMR metabolomics
Live-Cell Imaging

Microscopy & Optical Sensing

Ultra-low particulate background for confocal microscopy, biosensor measurements, and TEER monitoring on-chip.

ConfocalBiosensorsTEER
Technical Specifications

Analytical release specifications

Every lot released against the full specification matrix. Certificate of Analysis available: support@diagnocine.com. Pack sizes: 500 mL, 1000 mL.

Physical & Chemical Parameters
Parameter Specification
Formulation [+] Sodium Bicarbonate, [+] Phenol Red, [+] HEPES (25mM), [+] Calcium, [+] Magnesium, [+] High Glucose [-] L-Glutamine, [-] Sodium Pyruvate
Appearance Red-colored, clear solution
Total ingredients 39, across 4 categories (Inorganic Salts, Amino Acids, Vitamins, Others)
pH USP <791> 7.4
Osmolality USP <785> Contact for specification
Glucose 4500.000 mg/L
L-Glutamine None / Not added
Sodium Pyruvate None / Not added
Phenol Red 5.300 mg/L
Sterility, Purity & Safety
Parameter Specification
Endotoxin USP <85> BET < 0.05 EU/mL
Sterility USP <71> No growth / 14 days
Mycoplasma 0.1 µm mycoplasma-retentive filtration (not tested per lot)
Particulate ≥10 µm USP <788> Method 1 NMT 25/mL
Particulate ≥25 µm USP <788> Method 1 NMT 3/mL
Water purity Type 1, 18.2 MΩ·cm
Manufacturing std. ISO ISO 13485:2016
Fill environment ISO Class 5 (Class 100)
Storage, Handling & Logistics
Parameter Specification
Storage temperature 2–8°C, away from light
Freeze-thaw Do not freeze
Shelf life 12 months from date of manufacture, unopened
Shipping condition Cold pack
CO₂ requirement 5% CO₂ recommended (sodium bicarbonate primary buffer; 25 mM HEPES adds supplemental buffering for open-bench handling)
Raw Materials & Regulatory
Parameter Specification
Raw material grade Reagent / cell culture grade
Traceability Full lot traceability per ISO 13485
Manufacturing QMS ISO ISO 13485:2016 certified
UNSPSC 41116155 — Molecular biology and cell culture growth media (UNv260801)
Regulatory alignment 21 CFR Part 820 (QMSR) aligned
Production method Micro-batch, per-lot QC release
Intended use Research Use Only (RUO)
Formulation

Full composition (mg/L)

RPMI 1640 Medium, High Glucose & 25mM HEPES w/o L-Glutamine, Sodium Pyruvate: 1X Liquid: 39 ingredients verified per lot with CAS numbers for full raw-material traceability. All ingredients from the original formulation are preserved exactly.

Component CAS Number mg/L
INORGANIC SALTS
Calcium nitrate tetrahydrate 13477-34-4 100.000
Magnesium sulfate anhydrous 7487-88-9 48.840
Potassium chloride 7447-40-7 400.000
Sodium bicarbonate 144-55-8 2000.000
Sodium chloride 7647-14-5 6000.00
Sodium phosphate dibasic anhydrous 7558-79-4 800.000
Component CAS Number mg/L
AMINO ACIDS
Glycine 56-40-6 10.000
L-Arginine hydrochloride 1119-34-2 241.000
L-Asparagine 70-47-3 50.000
L-Aspartic acid 56-84-8 20.000
L-Cystine dihydrochloride 30925-07-6 65.200
L-Glutamic acid 56-86-0 20.000
L-Histidine hydrochloride monohydrate 5934-29-2 20.960
L-Hydroxyproline 51-35-4 20.000
L-Isoleucine 73-32-5 50.000
L-Leucine 61-90-5 50.000
L-Lysine hydrochloride 657-27-2 40.000
L-Methionine 63-68-3 15.000
L-Phenylalanine 63-91-2 15.000
L-Proline 147-85-3 20.000
L-Serine 56-45-1 30.000
L-Threonine 72-19-5 20.000
L-Tryptophan 73-22-3 5.000
L-Tyrosine Disodium Salt 69847-45-6 28.830
L-Valine 72-18-4 20.000
Component CAS Number mg/L
VITAMINS
Choline chloride 67-48-1 3.000
D-Biotin 58-85-5 0.200
D-Ca-Pantothenate 137-08-6 0.250
Folic acid 59-30-3 1.000
Niacinamide 98-92-0 1.000
Pyridoxine hydrochloride 58-56-0 1.000
Riboflavin 83-88-5 0.200
Thiamine hydrochloride 67-03-8 1.000
p-Amino benzoic acid (PABA) 150-13-0 1.000
OTHERS
D-Glucose 50-99-7 4500.000
Glutathione reduced 70-18-8 1.000
HEPES 7365-45-9 5958.000
i-Inositol 87-89-8 35.000
Phenol red sodium salt 34487-61-1 5.300
Customization available: pH, glucose, HEPES, salts, and nutrient composition modifications available on request. Contact support@diagnocine.com.
Quality Assurance

ISO 13485 Manufacturing & Compliance

Every batch of FluxMPS™ DCP-RPMIGH-QP1X is manufactured under a certified ISO 13485:2016 QMS with full lot traceability and multi-parameter QC release testing.

verified

ISO 13485:2016 QMS

Full quality management system with documented procedures, deviation control, and CAPA. Every lot traceable from raw material to final release.

water_drop

Ultrapure Type 1 Water

18.2 MΩ·cm resistivity with tight trace-metal and TOC control at the manufacturing source.

biotech

ISO Class 5 Fill & Finish

Final aseptic filling in ISO Class 5 (Class 100) cleanroom. Immediate post-filtration fill to prevent recontamination.

assignment

Micro-Batch Precision

Small-batch manufacturing with per-lot QC release. Every batch tested independently — not pooled or blended across lots.

Endotoxin USP <85> BET

LAL assay per batch. Release specification: < 0.05 EU/mL.

Particulate USP <788> Method 1

Light obscuration particulate analysis. NMT 25/mL at ≥10 µm; NMT 3/mL at ≥25 µm.

Osmolality USP <785>

Osmolality verified per lot using vapor pressure or freezing-point depression osmometry per USP <785>.

Documentation / CoA

Full Certificate of Analysis available per lot, including all QC parameters, test dates, and raw material lot numbers. Request: support@diagnocine.com.

Batch-level quality control. Endotoxin is controlled per manufacturing batch rather than per unit. Every batch is tested before release and must meet the release specification:
  • Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
  • pH, osmolality, conductivity, appearance and clarity
  • Sterility
A Certificate of Analysis is available on request at support@diagnocine.com.
Product Comparison

How DCP-RPMIGH-QP1X compares

FluxMPS™ versus conventional 0.22 µm filtered media for OoC and MPS applications.

Parameter DCP-RPMIGH-QP1X (FluxMPS™) Conventional 0.22 µm Filtered Standard Alternative
Grade Microfluidics Suitable Standard (0.22 µm) Standard (0.22 µm)
Formulation [+] Sodium Bicarbonate, [+] Phenol Red, [+] HEPES (25mM) [-] L-Glutamine, [-] Sodium Pyruvate Standard RPMI 1640 Standard RPMI 1640
Final filtration pore size 0.04 µm 0.22 µm 0.22 µm
Number of filtration stages 4 stages 1 stage 1–2 stages
Mycoplasma-retentive filtration check_circle cancel cancel
Endotoxin (release specification) < 0.05 EU/mL Corning classical liquid media — < 0.25 EU/mL
Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL
Gibco classical DMEM — Not specified (recorded per lot)
USP particulate compliance check_circle cancel cancel
Water quality Type 1, 18.2 MΩ·cm Type 2 typical Type 2 typical
Manufacturing QMS ISO 13485:2016 ISO 9001 typical Variable
Microfluidic channel compatibility check_circle cancel cancel
Custom formulation check_circle cancel Limited

Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".

FAQ

Frequently asked questions

Common questions about FluxMPS™ DCP-RPMIGH-QP1X and its use in OoC and MPS applications.

Yes. DCP-RPMIGH-QP1X is Microfluidics Suitable and specifically formulated for MPS and OoC platforms. The 0.04 µm final filtration reduces microfluidic channel fouling, making it suitable for OoC, ToC, BoC, and LoC applications with sensitivity to particulate contamination.
FluxMPS uses a Quadruple-stage system (0.1 µm ×2 + 0.04 µm ×2), providing approximately 5× lower particulate counts and a dedicated 0.1 µm mycoplasma-retentive filtration stage that standard 0.22 µm filtration does not include.
This formulation is supplied without L-Glutamine and without Sodium Pyruvate so you can add either at the concentration your protocol requires — L-glutamine or a stable dipeptide substitute (e.g. GlutaMAX-type supplements) at time of use, and sodium pyruvate if your cell type benefits from an additional carbon/redox source. High glucose (4.5 g/L) is already present in this formulation, so do not add supplemental glucose unless your protocol specifically calls for it.
Yes, 5% CO₂ is recommended. This formulation contains sodium bicarbonate (2000 mg/L) as its primary buffering system to maintain pH 7.4 under 5% CO₂; the added 25 mM HEPES provides supplemental buffering capacity useful during open-bench handling outside the incubator.
Yes. This is a basal medium formulation. Supplement with FBS, serum replacements, growth factors, L-glutamine, or sodium pyruvate as required by your cell type and protocol. When adding serum or other protein-containing supplements, filter using a 0.2 µm low-protein-binding PES or PVDF membrane; do not use a 0.04 µm membrane for serum-containing additions, as it will retain much of the protein and lipoprotein fraction.
Endotoxin is controlled per manufacturing batch to a release specification of < 0.05 EU/mL, verified by the Limulus Amebocyte Lysate (LAL) Bacterial Endotoxin Test (BET) per USP <85> (assay sensitivity 0.005 EU/mL) for every production batch prior to release.
Yes. A CoA is available per batch upon request at support@diagnocine.com. It includes pH, osmolality, endotoxin, sterility, mycoplasma-retentive filtration status, USP <788> particulate data, appearance, and full raw material lot traceability.
Scientific References

Supporting literature

Curated peer-reviewed references relevant to OoC and MPS applications and FluxMPS™ ultra-filtered cell culture media applications.

  1. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nature Biotechnology. 2014;32(8):760–772.doi:10.1038/nbt.2989
  2. Sackmann EK, Fulton AL, Beebe DJ. The present and future role of microfluidics in biomedical research. Nature. 2014;507(7491):181–189.doi:10.1038/nature13118
  3. Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328(5986):1662–1668.doi:10.1126/science.1188302
  4. Ingber DE. Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies? Advanced Science. 2020;7(22):2002162.doi:10.1002/advs.202002162
  5. Maoz BM, et al. A linked organ-on-chip model of the human neurovascular unit reveals the metabolic landscape of brain disease. Nature Biotechnology. 2018;36:865–874.doi:10.1038/nbt.4226
  6. Bhise NS, et al. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication. 2016;8(1):014101.doi:10.1088/1758-5090/8/1/014101
  7. Luni C, Serena E, Elvassore N. Human-on-chip for therapy development and fundamental science. Current Opinion in Biotechnology. 2014;25:45–50.doi:10.1016/j.copbio.2013.08.015
  8. Erickson KA, Bhansali S. Mycoplasma contamination in cell cultures: a survey of incidence and approaches to prevention. Journal of the Association for Laboratory Automation. 2012;17(5):346–354.doi:10.1177/2211068212456089
  9. van Duinen V, et al. Microfluidic 3D cell culture: from tools to tissue models. Current Opinion in Biotechnology. 2015;35:118–126.doi:10.1016/j.copbio.2015.05.002
  10. Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314.doi:10.1126/science.123.3191.309

Satisfaction
Quality Rating
Value Rating
Style Rating
X